Article Text

PDF
Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the R86X mutation in the HAX1 gene
  1. N Ishikawa1,
  2. S Okada1,
  3. M Miki1,
  4. K Shirao1,
  5. H Kihara1,
  6. M Tsumura1,
  7. K Nakamura1,
  8. H Kawaguchi1,
  9. M Ohtsubo2,
  10. S Yasunaga2,
  11. K Matsubara3,
  12. M Sako1,4,
  13. J Hara4,
  14. M Shiohara5,
  15. S Kojima6,
  16. T Sato1,
  17. Y Takihara2,
  18. M Kobayashi1
  1. 1
    Department of Pediatrics, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan
  2. 2
    Department of Stem Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima, Japan
  3. 3
    Department of Pediatrics, Nishi-Kobe Medical Center, Kobe, Japan
  4. 4
    Department of Pediatric Hematology/Oncology, Children’s Medical Center, Osaka City General Hospital, Osaka, Japan
  5. 5
    Department of Pediatrics, Shinshu University Faculty of Medicine, Matsumoto, Japan
  6. 6
    Department of Pediatrics, Nagoya University School of Medicine, Nagoya, Japan
  1. Dr M Kobayashi, Department of Pediatrics, Hiroshima, University Graduate School of Biomedical Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551 Japan; masak{at}hiroshima-u.ac.jp

Abstract

Objective: Severe congenital neutropenia (SCN), also known as Kostmann syndrome (SCN3, OMIM 610738), includes a variety of haematological disorders caused by different genetic abnormalities. Mutations in ELA2 are most often the cause in autosomal dominant or sporadic forms. Recently, mutations in HAX1 have been identified as the cause of some autosomal recessive forms of SCN, including those present in the original pedigree first reported by Kostmann. We sought to determine the relationship between HAX1 gene mutations and the clinical characteristics of Japanese cases of SCN.

Methods: The genes implicated in SCN (ELA2, HAX1, Gfi-1, WAS, and P14) were analysed in 18 Japanese patients with SCN. The clinical features of these patients were obtained from medical records. Immunoblotting of HAX1 was performed on cell extracts from peripheral blood leucocytes from patients and/or their parents.

Results: We found five patients with HAX1 deficiency and 11 patients with mutations in the ELA2 gene. In HAX1 deficiency, a homozygous single base pair substitution (256C>T), which causes the nonsense change R86X, was identified in three affected individuals. Two sibling patients showed a compound heterozygous mutation consisting of a single base pair substitution (256C>T) and a 59 bp deletion at nucleotides 376–434. There was no detectable phenotype in any heterozygous carrier. All patients with HAX1 deficiency had experienced developmental delay. Three patients carrying R86X also suffered from epileptic seizures. In contrast, no SCN patient with heterozygous mutations in the ELA2 gene suffered from any neurodevelopmental abnormality.

Conclusions: These findings suggest that the R86X mutation in the HAX1 gene is an abnormality in Japanese SCN patients with HAX1 deficiency and may lead to neurodevelopmental abnormalities and severe myelopoietic defects.

Statistics from Altmetric.com

Footnotes

  • ▸ An additional figure is published online only at http://jmg.bmj.com/content/vol45/issue12

  • Funding: This study was supported in part by a grant (to MK) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and by a grant from the Ministry of Health, Labour and Welfare, Japan.

  • Competing interests: None.

  • Patient consent: Obtained.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.